InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by HOMBACH ROBERT J., Director. Officer active across 5 companies, notably Biomarin Pharmaceutical INC. In total, 10 reports have been logged. Total volume traded: €45k. The latest transaction was filed on 24 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
04,980 shares0
Common Stock
SEC:0001567619-22-011794:0·
06,024 shares0
Common Stock
SEC:0001209191-22-023177:0·
€11,2835,400 shares@ €2.089550.0% of flow
Common Stock
SEC:0001415889-21-005223·
Ideal exit: 8 Aug 2022 (T+270)
€11,2835,400 shares@ €2.089525.0% of flow
Common Stock
SEC:0001415889-21-005223:0·
Ideal exit: 8 Aug 2022 (T+270)
€11,2835,400 shares@ €2.089550.0% of flow
Common Stock
SEC:0001415889-21-005202·
Ideal exit: 8 Aug 2022 (T+270)
€11,2835,400 shares@ €2.089525.0% of flow
Common Stock
SEC:0001415889-21-005202:0·
Ideal exit: 8 Aug 2022 (T+270)
01,308 shares0
Common Stock
SEC:0001170010-21-000150·
01,308 shares0
Common Stock
SEC:0001170010-21-000150:0·
05,120 shares0
Common Stock
SEC:0001567619-21-011309·
05,120 shares0
Common Stock
SEC:0001567619-21-011309:0·
10 of 10 declarations
About HOMBACH ROBERT J.
Robert J. Hombach is a Board Member at BioMarin Pharmaceutical Inc., CarMax Inc., and Aptinyx Inc. With a strong background in the pharmaceutical and automotive industries, he contributes to the governance and strategy of these companies. His role includes overseeing performance and evaluating growth opportunities.
